Remove FDA Remove Information Remove Informed Consent
article thumbnail

FDA Issues Final Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors

Health Law Advisor

Food and Drug Administration (“FDA”) released final guidance on informed consent for clinical investigations (“Final Guidance”). This update follows FDA’s draft guidance, which was issued in July 2014, and supersedes the FDA’s “A Guide to Informed Consent,” which was issued in September 1998.

article thumbnail

FDA Finalizes Its Informed Consent Guidance for IRBs, Clinical Investigators and Sponsors

Hall Render

Food and Drug Administration (“FDA”) finalized “ Informed Consent: Guidance for IRBs, Clinical Investigators, and Sponsors ” (“Final Guidance”), following the FDA’s earlier issuance of draft guidance on the subject in July 2014. On August 15, 2023, the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA releases guidance for remotely acquiring data in clinical investigations

Healthcare IT News - Telehealth

"Compared to intermittent trial visits, the use of DHTs to remotely collect data from trial participants may allow for continuous or more frequent data collection," said FDA officials. The FDA notes that digital health tools used for remote data acquisition can offer an important role in clinical research. WHY IT MATTERS.

FDA 197
article thumbnail

AI’s Ability to Manipulate Decision Making Requires a Moratorium on Its Use in Obtaining Consent for Biomedical Research

Bill of Health

The federal government’s commitment to assuring that participants in human subject research provide fully informed consent dates back to the U.S In 2017, Congress acted again to update the Common Rule and strengthen the provisions related to consent. While the U.S. These warnings echo those of the U.S.

article thumbnail

Everything You Wanted to Know About Expanded Access but Were Afraid to Ask, Part 1

Bill of Health

Food and Drug Administration or FDA), which contributes to the development of knowledge about the unapproved product’s safety. Patients seeking to use a product via EA must have a serious or life-threatening condition for which there are no comparable FDA-approved treatments or clinical trial options available.

FDA 237
article thumbnail

Reflections on Procedural Barriers to Pediatric COVID Vaccine Access

Bill of Health

Food and Drug Administration (FDA), many parents felt a glimmer of hope after a long time. For example, the group organized a physician coalition letter where several hundred doctors called on the FDA to urgently cut the bureaucratic tape and make vaccines accessible to young children. Solutions for the Future.

COVID-19 344
article thumbnail

Why We Should Care About the Move from Saliva to Living Cells in Precision Medicine

Bill of Health

By Adithi Iyer The cultural, informational, and medical phenomenon that is 23andMe has placed a spotlight on precision medicine, which seeks to personalize medical care to each patient’s unique makeup. This information is highly personal to each patient, and reflects behavioral factors as well as genetics.

FDA 282